SILO PHARMA, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SILO PHARMA, INC. (SILO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 698.84 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- SILO PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 10.48M shares, a 369.09% increase year-over-year.
- SILO PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 2.23M shares, a 415.56% increase year-over-year.
- SILO PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 433.43K shares, a 90.00% decline year-over-year.
- SILO PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 4.33M shares, a 1052.94% increase year-over-year.
- SILO PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 433.43K shares, a 17.71% increase from fiscal 2021.
- SILO PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 368.21K shares, a 22.74% increase from fiscal 2020.
- SILO PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 300.00K shares.
- SILO PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 2.00M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 698.84K shares 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | 10.48M shares 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | 10.76M shares POS AM · filed 2026-04-14 | |||||||
| 2025-09-30 | 7.70M shares 10-Q · filed 2025-11-13 | |||||||
| 2025-06-30 | 581.21K shares 10-Q · filed 2026-08-13 | 8.72M shares 10-Q · filed 2025-08-13 | ||||||
| 2025-03-31 | 2.23M shares 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | 2.23M shares POS AM · filed 2026-04-14 | |||||||
| 2024-09-30 | 2.24M shares 10-Q · filed 2025-11-13 | |||||||
| 2024-06-30 | 1.42M shares 10-Q · filed 2025-08-13 | |||||||
| 2024-03-31 | 433.43K shares 10-Q · filed 2024-05-13 | |||||||
| 2023-12-31 | 433.43K shares 10-Q · filed 2025-05-09 | 433.43K shares 10-K · filed 2024-03-25 | ||||||
| 2023-09-30 | 433.43K shares 10-Q · filed 2024-11-12 | 433.43K shares 10-Q · filed 2023-11-13 | ||||||
| 2023-06-30 | 433.43K shares 10-Q · filed 2024-08-13 | 433.43K shares 10-Q · filed 2023-08-11 | ||||||
| 2023-03-31 | 4.33M shares 10-Q · filed 2024-05-13 | 433.43K shares 10-Q · filed 2023-05-12 | ||||||
| 2022-12-31 | 433.43K shares 10-K · filed 2024-03-25 | |||||||
| 2022-09-30 | 433.43K shares 10-Q · filed 2023-11-13 | |||||||
| 2022-06-30 | 375.93K shares 10-Q · filed 2023-08-11 | 18.80M shares 10-Q · filed 2022-08-01 | ||||||
| 2022-03-31 | 375.93K shares 10-Q · filed 2023-05-12 | 18.45M shares 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | 368.21K shares 10-K · filed 2023-03-24 | 18.41M shares 10-K · filed 2022-03-28 | ||||||
| 2021-09-30 | 368.08K shares 10-Q · filed 2022-11-10 | |||||||
| 2021-06-30 | 18.41M shares 10-Q · filed 2022-08-01 | |||||||
| 2021-03-31 | 31.91M shares 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | 300.00K shares 10-K · filed 2022-03-28 | |||||||
| 2019-03-31 | 2.00M shares 10-Q · filed 2019-05-14 | |||||||
| 2018-12-31 | 2.00M shares 10-K · filed 2019-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |